Transient carnitine transport defect with cholestatic jaundice: report of one case in a premature baby

Carnitine (β-hydroxy-γ-trimethylaminobutyric acid) is involved in the transport of long-chain fatty acids into the mitochondrial matrix and the removal of potentially toxic acylcarnitine esters. Transient carnitine transport defect is a rare condition in newborns reported in 1/90,000 live births. In...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental pediatrics Vol. 55; no. 2; pp. 58 - 62
Main Authors Cho, Hyun-Seok, Choo, Young Kwang, Lee, Hong Jin, Lee, Hyeon-Soo
Format Journal Article
LanguageEnglish
Published Korea (South) Clinical and Experimental Pediatics / Korean Pediatric Society 01.02.2012
The Korean Pediatric Society
Korean Pediatric Society
대한소아청소년과학회
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Carnitine (β-hydroxy-γ-trimethylaminobutyric acid) is involved in the transport of long-chain fatty acids into the mitochondrial matrix and the removal of potentially toxic acylcarnitine esters. Transient carnitine transport defect is a rare condition in newborns reported in 1/90,000 live births. In this paper, we describe a case of transient carnitine transport defect found in a premature baby who had prolonged cholestatic jaundice and poor weight gain, and who responded dramatically to oral carnitine supplementation.
Bibliography:G704-000560.2012.55.2.002
ISSN:1738-1061
2092-7258
2713-4148
DOI:10.3345/kjp.2012.55.2.58